You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港醫思醫療集團(02138.HK)擬配發480.54萬股股份
格隆匯 09-24 19:53

格隆匯 9 月 24日丨香港醫思醫療集團(02138.HK)發佈公告,2020年9月24日,認購方與公司訂立簽署認購協議,據此,公司已有條件同意配發及發行480.54萬股每股認購價為4.25港元的認購股份。認購方應付的總代價為2040萬港元。

每股認購股份的認購價4.25港元較收市價每股4.55港元折讓約6.59%。認購股份佔於該公告日期公司現有已發行股本約0.469%,並佔緊認購股份發行後公司的經擴大已發行股本約0.466%。公司將向聯交所申請批准認購股份上市及允許進行買賣。

根據披露,認購方Renaissance City Development Company Limited,是於香港註冊成立的有限公司及冠君產業信託(02778.HK)的全資附屬公司。其主要業務為物業投資,與冠君產業信託的另一間附屬公司(作為若干單位的業主)已分別與公司的兩家附屬公司(作為朗豪坊辦公大樓物業的租户)簽訂了若干租賃協議。認購事項所得款項約為2040萬港元,已與租賃款項作抵銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account